Medical Care
Global Small Molecule Targeted Cancer Therapy Market Research Report 2025
- Mar 11, 25
- ID: 6956
- Pages: 97
- Figures: 94
- Views: 3
The global market for Small Molecule Targeted Cancer Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Most targeted therapies are either small-molecule drugs or monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells. Monoclonal antibodies, also known as therapeutic antibodies, are proteins produced in the lab.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Cancer Therapy.
The Small Molecule Targeted Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule Targeted Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Targeted Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Gilead Sciences
Boehringer Ingelheim
Abbott Laboratories
Bayer AG
GSK
AstraZeneca
Johnson & Johnson
Teva
Pfizer
Allergan
Merck
Novartis
Sanofi
Amgen
AbbVie
Eli Lilly
Segment by Type
Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates
Segment by Application
Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Targeted Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Most targeted therapies are either small-molecule drugs or monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells. Monoclonal antibodies, also known as therapeutic antibodies, are proteins produced in the lab.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Cancer Therapy.
The Small Molecule Targeted Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule Targeted Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Targeted Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Gilead Sciences
Boehringer Ingelheim
Abbott Laboratories
Bayer AG
GSK
AstraZeneca
Johnson & Johnson
Teva
Pfizer
Allergan
Merck
Novartis
Sanofi
Amgen
AbbVie
Eli Lilly
Segment by Type
Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates
Segment by Application
Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Targeted Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecules
1.2.4 Small Molecule Drug Conjugates
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lymphoma
1.3.3 Melanoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Cancer Therapy Market Perspective (2020-2031)
2.2 Global Small Molecule Targeted Cancer Therapy Growth Trends by Region
2.2.1 Global Small Molecule Targeted Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule Targeted Cancer Therapy Market Dynamics
2.3.1 Small Molecule Targeted Cancer Therapy Industry Trends
2.3.2 Small Molecule Targeted Cancer Therapy Market Drivers
2.3.3 Small Molecule Targeted Cancer Therapy Market Challenges
2.3.4 Small Molecule Targeted Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue
3.1.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue (2020-2025)
3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule Targeted Cancer Therapy Revenue
3.4 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2024
3.5 Global Key Players of Small Molecule Targeted Cancer Therapy Head office and Area Served
3.6 Global Key Players of Small Molecule Targeted Cancer Therapy, Product and Application
3.7 Global Key Players of Small Molecule Targeted Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Cancer Therapy Breakdown Data by Type
4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2026-2031)
5 Small Molecule Targeted Cancer Therapy Breakdown Data by Application
5.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
6.2 North America Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
9.2 Latin America Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
9.4 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Small Molecule Targeted Cancer Therapy Introduction
11.1.4 Roche Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Small Molecule Targeted Cancer Therapy Introduction
11.2.4 Gilead Sciences Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Introduction
11.3.4 Boehringer Ingelheim Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
11.4.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.4.5 Abbott Laboratories Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Small Molecule Targeted Cancer Therapy Introduction
11.5.4 Bayer AG Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.5.5 Bayer AG Recent Development
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Small Molecule Targeted Cancer Therapy Introduction
11.6.4 GSK Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.6.5 GSK Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Small Molecule Targeted Cancer Therapy Introduction
11.7.4 AstraZeneca Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Small Molecule Targeted Cancer Therapy Introduction
11.8.4 Johnson & Johnson Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.8.5 Johnson & Johnson Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Small Molecule Targeted Cancer Therapy Introduction
11.9.4 Teva Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.9.5 Teva Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Small Molecule Targeted Cancer Therapy Introduction
11.10.4 Pfizer Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Allergan
11.11.1 Allergan Company Details
11.11.2 Allergan Business Overview
11.11.3 Allergan Small Molecule Targeted Cancer Therapy Introduction
11.11.4 Allergan Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.11.5 Allergan Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Small Molecule Targeted Cancer Therapy Introduction
11.12.4 Merck Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.12.5 Merck Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Small Molecule Targeted Cancer Therapy Introduction
11.13.4 Novartis Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.13.5 Novartis Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Small Molecule Targeted Cancer Therapy Introduction
11.14.4 Sanofi Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.14.5 Sanofi Recent Development
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Small Molecule Targeted Cancer Therapy Introduction
11.15.4 Amgen Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.15.5 Amgen Recent Development
11.16 AbbVie
11.16.1 AbbVie Company Details
11.16.2 AbbVie Business Overview
11.16.3 AbbVie Small Molecule Targeted Cancer Therapy Introduction
11.16.4 AbbVie Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.16.5 AbbVie Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Company Details
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly Small Molecule Targeted Cancer Therapy Introduction
11.17.4 Eli Lilly Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.17.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecules
1.2.4 Small Molecule Drug Conjugates
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lymphoma
1.3.3 Melanoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Cancer Therapy Market Perspective (2020-2031)
2.2 Global Small Molecule Targeted Cancer Therapy Growth Trends by Region
2.2.1 Global Small Molecule Targeted Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule Targeted Cancer Therapy Market Dynamics
2.3.1 Small Molecule Targeted Cancer Therapy Industry Trends
2.3.2 Small Molecule Targeted Cancer Therapy Market Drivers
2.3.3 Small Molecule Targeted Cancer Therapy Market Challenges
2.3.4 Small Molecule Targeted Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue
3.1.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue (2020-2025)
3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule Targeted Cancer Therapy Revenue
3.4 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2024
3.5 Global Key Players of Small Molecule Targeted Cancer Therapy Head office and Area Served
3.6 Global Key Players of Small Molecule Targeted Cancer Therapy, Product and Application
3.7 Global Key Players of Small Molecule Targeted Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Cancer Therapy Breakdown Data by Type
4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2026-2031)
5 Small Molecule Targeted Cancer Therapy Breakdown Data by Application
5.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
6.2 North America Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
9.2 Latin America Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
9.4 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Small Molecule Targeted Cancer Therapy Introduction
11.1.4 Roche Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Small Molecule Targeted Cancer Therapy Introduction
11.2.4 Gilead Sciences Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.2.5 Gilead Sciences Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Introduction
11.3.4 Boehringer Ingelheim Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
11.4.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.4.5 Abbott Laboratories Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Small Molecule Targeted Cancer Therapy Introduction
11.5.4 Bayer AG Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.5.5 Bayer AG Recent Development
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Small Molecule Targeted Cancer Therapy Introduction
11.6.4 GSK Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.6.5 GSK Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Small Molecule Targeted Cancer Therapy Introduction
11.7.4 AstraZeneca Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Small Molecule Targeted Cancer Therapy Introduction
11.8.4 Johnson & Johnson Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.8.5 Johnson & Johnson Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Small Molecule Targeted Cancer Therapy Introduction
11.9.4 Teva Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.9.5 Teva Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Small Molecule Targeted Cancer Therapy Introduction
11.10.4 Pfizer Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Allergan
11.11.1 Allergan Company Details
11.11.2 Allergan Business Overview
11.11.3 Allergan Small Molecule Targeted Cancer Therapy Introduction
11.11.4 Allergan Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.11.5 Allergan Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Small Molecule Targeted Cancer Therapy Introduction
11.12.4 Merck Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.12.5 Merck Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Small Molecule Targeted Cancer Therapy Introduction
11.13.4 Novartis Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.13.5 Novartis Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Small Molecule Targeted Cancer Therapy Introduction
11.14.4 Sanofi Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.14.5 Sanofi Recent Development
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Small Molecule Targeted Cancer Therapy Introduction
11.15.4 Amgen Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.15.5 Amgen Recent Development
11.16 AbbVie
11.16.1 AbbVie Company Details
11.16.2 AbbVie Business Overview
11.16.3 AbbVie Small Molecule Targeted Cancer Therapy Introduction
11.16.4 AbbVie Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.16.5 AbbVie Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Company Details
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly Small Molecule Targeted Cancer Therapy Introduction
11.17.4 Eli Lilly Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025)
11.17.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small Molecules
Table 4. Key Players of Small Molecule Drug Conjugates
Table 5. Global Small Molecule Targeted Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Small Molecule Targeted Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Small Molecule Targeted Cancer Therapy Market Share by Region (2020-2025)
Table 9. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Small Molecule Targeted Cancer Therapy Market Share by Region (2026-2031)
Table 11. Small Molecule Targeted Cancer Therapy Market Trends
Table 12. Small Molecule Targeted Cancer Therapy Market Drivers
Table 13. Small Molecule Targeted Cancer Therapy Market Challenges
Table 14. Small Molecule Targeted Cancer Therapy Market Restraints
Table 15. Global Small Molecule Targeted Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Small Molecule Targeted Cancer Therapy Market Share by Players (2020-2025)
Table 17. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2024)
Table 18. Ranking of Global Top Small Molecule Targeted Cancer Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Small Molecule Targeted Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Small Molecule Targeted Cancer Therapy, Headquarters and Area Served
Table 21. Global Key Players of Small Molecule Targeted Cancer Therapy, Product and Application
Table 22. Global Key Players of Small Molecule Targeted Cancer Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche Small Molecule Targeted Cancer Therapy Product
Table 50. Roche Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Gilead Sciences Company Details
Table 53. Gilead Sciences Business Overview
Table 54. Gilead Sciences Small Molecule Targeted Cancer Therapy Product
Table 55. Gilead Sciences Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 56. Gilead Sciences Recent Development
Table 57. Boehringer Ingelheim Company Details
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Product
Table 60. Boehringer Ingelheim Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product
Table 65. Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 66. Abbott Laboratories Recent Development
Table 67. Bayer AG Company Details
Table 68. Bayer AG Business Overview
Table 69. Bayer AG Small Molecule Targeted Cancer Therapy Product
Table 70. Bayer AG Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 71. Bayer AG Recent Development
Table 72. GSK Company Details
Table 73. GSK Business Overview
Table 74. GSK Small Molecule Targeted Cancer Therapy Product
Table 75. GSK Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 76. GSK Recent Development
Table 77. AstraZeneca Company Details
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Small Molecule Targeted Cancer Therapy Product
Table 80. AstraZeneca Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Small Molecule Targeted Cancer Therapy Product
Table 85. Johnson & Johnson Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Teva Company Details
Table 88. Teva Business Overview
Table 89. Teva Small Molecule Targeted Cancer Therapy Product
Table 90. Teva Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 91. Teva Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Small Molecule Targeted Cancer Therapy Product
Table 95. Pfizer Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. Allergan Company Details
Table 98. Allergan Business Overview
Table 99. Allergan Small Molecule Targeted Cancer Therapy Product
Table 100. Allergan Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 101. Allergan Recent Development
Table 102. Merck Company Details
Table 103. Merck Business Overview
Table 104. Merck Small Molecule Targeted Cancer Therapy Product
Table 105. Merck Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 106. Merck Recent Development
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Small Molecule Targeted Cancer Therapy Product
Table 110. Novartis Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 111. Novartis Recent Development
Table 112. Sanofi Company Details
Table 113. Sanofi Business Overview
Table 114. Sanofi Small Molecule Targeted Cancer Therapy Product
Table 115. Sanofi Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 116. Sanofi Recent Development
Table 117. Amgen Company Details
Table 118. Amgen Business Overview
Table 119. Amgen Small Molecule Targeted Cancer Therapy Product
Table 120. Amgen Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 121. Amgen Recent Development
Table 122. AbbVie Company Details
Table 123. AbbVie Business Overview
Table 124. AbbVie Small Molecule Targeted Cancer Therapy Product
Table 125. AbbVie Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 126. AbbVie Recent Development
Table 127. Eli Lilly Company Details
Table 128. Eli Lilly Business Overview
Table 129. Eli Lilly Small Molecule Targeted Cancer Therapy Product
Table 130. Eli Lilly Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 131. Eli Lilly Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
Table 135. Authors List of This Report
List of Figures
Figure 1. Small Molecule Targeted Cancer Therapy Picture
Figure 2. Global Small Molecule Targeted Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Small Molecule Targeted Cancer Therapy Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibodies Features
Figure 5. Small Molecules Features
Figure 6. Small Molecule Drug Conjugates Features
Figure 7. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2024 VS 2031
Figure 9. Lymphoma Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Multiple Myeloma Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Small Molecule Targeted Cancer Therapy Report Years Considered
Figure 16. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Small Molecule Targeted Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Small Molecule Targeted Cancer Therapy Market Share by Region: 2024 VS 2031
Figure 19. Global Small Molecule Targeted Cancer Therapy Market Share by Players in 2024
Figure 20. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2024
Figure 22. North America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
Figure 24. United States Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
Figure 28. Germany Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Region (2020-2031)
Figure 36. China Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
Figure 44. Mexico Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
Figure 48. Turkey Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Roche Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 52. Gilead Sciences Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 54. Abbott Laboratories Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 55. Bayer AG Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 56. GSK Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 58. Johnson & Johnson Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 59. Teva Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 60. Pfizer Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 61. Allergan Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 62. Merck Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 63. Novartis Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 64. Sanofi Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 65. Amgen Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 66. AbbVie Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 67. Eli Lilly Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small Molecules
Table 4. Key Players of Small Molecule Drug Conjugates
Table 5. Global Small Molecule Targeted Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Small Molecule Targeted Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Small Molecule Targeted Cancer Therapy Market Share by Region (2020-2025)
Table 9. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Small Molecule Targeted Cancer Therapy Market Share by Region (2026-2031)
Table 11. Small Molecule Targeted Cancer Therapy Market Trends
Table 12. Small Molecule Targeted Cancer Therapy Market Drivers
Table 13. Small Molecule Targeted Cancer Therapy Market Challenges
Table 14. Small Molecule Targeted Cancer Therapy Market Restraints
Table 15. Global Small Molecule Targeted Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Small Molecule Targeted Cancer Therapy Market Share by Players (2020-2025)
Table 17. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2024)
Table 18. Ranking of Global Top Small Molecule Targeted Cancer Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Small Molecule Targeted Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Small Molecule Targeted Cancer Therapy, Headquarters and Area Served
Table 21. Global Key Players of Small Molecule Targeted Cancer Therapy, Product and Application
Table 22. Global Key Players of Small Molecule Targeted Cancer Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche Small Molecule Targeted Cancer Therapy Product
Table 50. Roche Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Gilead Sciences Company Details
Table 53. Gilead Sciences Business Overview
Table 54. Gilead Sciences Small Molecule Targeted Cancer Therapy Product
Table 55. Gilead Sciences Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 56. Gilead Sciences Recent Development
Table 57. Boehringer Ingelheim Company Details
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Product
Table 60. Boehringer Ingelheim Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product
Table 65. Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 66. Abbott Laboratories Recent Development
Table 67. Bayer AG Company Details
Table 68. Bayer AG Business Overview
Table 69. Bayer AG Small Molecule Targeted Cancer Therapy Product
Table 70. Bayer AG Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 71. Bayer AG Recent Development
Table 72. GSK Company Details
Table 73. GSK Business Overview
Table 74. GSK Small Molecule Targeted Cancer Therapy Product
Table 75. GSK Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 76. GSK Recent Development
Table 77. AstraZeneca Company Details
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Small Molecule Targeted Cancer Therapy Product
Table 80. AstraZeneca Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Small Molecule Targeted Cancer Therapy Product
Table 85. Johnson & Johnson Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Teva Company Details
Table 88. Teva Business Overview
Table 89. Teva Small Molecule Targeted Cancer Therapy Product
Table 90. Teva Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 91. Teva Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Small Molecule Targeted Cancer Therapy Product
Table 95. Pfizer Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. Allergan Company Details
Table 98. Allergan Business Overview
Table 99. Allergan Small Molecule Targeted Cancer Therapy Product
Table 100. Allergan Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 101. Allergan Recent Development
Table 102. Merck Company Details
Table 103. Merck Business Overview
Table 104. Merck Small Molecule Targeted Cancer Therapy Product
Table 105. Merck Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 106. Merck Recent Development
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Small Molecule Targeted Cancer Therapy Product
Table 110. Novartis Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 111. Novartis Recent Development
Table 112. Sanofi Company Details
Table 113. Sanofi Business Overview
Table 114. Sanofi Small Molecule Targeted Cancer Therapy Product
Table 115. Sanofi Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 116. Sanofi Recent Development
Table 117. Amgen Company Details
Table 118. Amgen Business Overview
Table 119. Amgen Small Molecule Targeted Cancer Therapy Product
Table 120. Amgen Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 121. Amgen Recent Development
Table 122. AbbVie Company Details
Table 123. AbbVie Business Overview
Table 124. AbbVie Small Molecule Targeted Cancer Therapy Product
Table 125. AbbVie Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 126. AbbVie Recent Development
Table 127. Eli Lilly Company Details
Table 128. Eli Lilly Business Overview
Table 129. Eli Lilly Small Molecule Targeted Cancer Therapy Product
Table 130. Eli Lilly Revenue in Small Molecule Targeted Cancer Therapy Business (2020-2025) & (US$ Million)
Table 131. Eli Lilly Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
Table 135. Authors List of This Report
List of Figures
Figure 1. Small Molecule Targeted Cancer Therapy Picture
Figure 2. Global Small Molecule Targeted Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Small Molecule Targeted Cancer Therapy Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibodies Features
Figure 5. Small Molecules Features
Figure 6. Small Molecule Drug Conjugates Features
Figure 7. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2024 VS 2031
Figure 9. Lymphoma Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Multiple Myeloma Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Small Molecule Targeted Cancer Therapy Report Years Considered
Figure 16. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Small Molecule Targeted Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Small Molecule Targeted Cancer Therapy Market Share by Region: 2024 VS 2031
Figure 19. Global Small Molecule Targeted Cancer Therapy Market Share by Players in 2024
Figure 20. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2024
Figure 22. North America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
Figure 24. United States Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
Figure 28. Germany Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Region (2020-2031)
Figure 36. China Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
Figure 44. Mexico Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Country (2020-2031)
Figure 48. Turkey Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Roche Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 52. Gilead Sciences Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 54. Abbott Laboratories Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 55. Bayer AG Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 56. GSK Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 58. Johnson & Johnson Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 59. Teva Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 60. Pfizer Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 61. Allergan Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 62. Merck Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 63. Novartis Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 64. Sanofi Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 65. Amgen Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 66. AbbVie Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 67. Eli Lilly Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Multi-Channel Temperature Controllers Market Research Report 2025
Mar 14, 25
Global Waterproof Action Cameras Market Research Report 2025
Mar 14, 25
Global Infrared IP Cameras Market Research Report 2025
Mar 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232